A systematic review and meta-analysis of the association between depression and insulin resistance

Diabetes Care

Volumn 36, Issue 2, 2013, Pages 480-489

  Kan, Carol ^a   Silva, Naomi ^a   Golden, Sherita Hill ^b,c   Rajala, Ulla ^d   Timonen, Markku ^d   Stahl, Daniel ^a   Ismail, Khalida ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; DEPRESSION; DISEASE ASSOCIATION; EFFECT SIZE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; PREVALENCE; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL RATING SCALE; REVIEW; SYSTEMATIC REVIEW;

DEPRESSION; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; RISK FACTORS;

EID: 84873828669     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1442     Document Type: Review

References (59)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069-1078
2. Lustman PJ, Clouse RE. Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complications 2005;19:113-122
3. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001; 63:619-630
4. Ismail K, Winkley K, Stahl D, Chalder T, Edmonds M. A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality. Diabetes Care 2007;30:1473-1479
5. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005;28:2668-2672
6. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008;31:2383-2390
7. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097
8. Morris AA, Ahmed Y, Stoyanova N, et al. The association between depression and leptin is mediated by adiposity. Psycho-som Med 2012;74:483-488
9. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 2000;283:2008-2012
10. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323:42-46
11. Owens DK, LohrKN, Atkins D, et al. AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventionsdagency for healthcare research and quality and the effective healthcare program. J Clin Epidemiol 2010;63: 513-523
12. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, 1992
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC, American Psychiatric Association, 2000
14. StataCorp, Stata Statistical Software: Release 11. 2009
15. StataCorp, Stata Statistical Software: Release 10. 2007
16. Sterne JAC, Newton HJ, Cox NJ. Meta-Analysis in Stata: An Updated Collection from the Stata Journal. College Station, TX, Stata Press, 2009
17. Cooper HM, Hedges LV. The Handbook of Research Synthesis. New York, Russell Sage Foundation, 1994
18. Gilpin AR. Table for conversion of Kendall's Tau to Spearman's Rho within the context of measures of magnitude of effect for meta-analysis. Educ Psychol Meas 1993;53:87-92
19. Shen Q, Bergquist-Beringer S, Sousa VD. Major depressive disorder and insulin resistance in nondiabetic young adults in the United States: the National Health and Nutrition Examination Survey, 1999-2002. Biol Res Nurs 2011;13:175-181
20. Rosenthal, R. Meta-analytic Procedures For Social Research. Newbury Park, CA, Sage Publications, 1991
21. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. New York, John Wiley & Sons, 2009
22. Cochran WG. The comparison of percentages in matched samples. Biometrika 1950;37:256-266
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560
24. Thompson SGS, Sharp SJ. Explaining heterogeneity in meta-analysis: a comparison of methods.Stat Med 1999;18:2693-2708
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315: 629-634
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-1101
27. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. New York, John Wiley & Sons, 2011
28. Gilbey MP, Casale C, Lei S, et al. Prevalence and treatment of depression are differentially associated with insulin resistance and obesity. 1st Joint Meeting of the International Society for Autonomic Neuroscience and the American Auto-nomic Society (ISAN/AAS 2011), Buzios, Rio de Janeiro, Brazil, September 12-16, 2011(Abstracts). Clin Auton Res 2011; 21:215-308
29. Lawlor DA, Smith GD, Ebrahim S; British Women's Heart and Health Study. Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study. BMJ 2003;327:1383-1384
30. Lawlor DA, Ben-Shlomo Y, Ebrahim S, et al. Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly prospective cohort study. BMJ 2005;330:705-706
31. Chiba M, Suzuki S, Hinokio Y, et al. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 2000;49:1145-1149
32. Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinänen-Kiukaanniemi S. Insulin resistance and depression: cross sectional study. BMJ 2005;330:17-18
33. Adriaanse MC, Dekker JM, Nijpels G, Heine RJ, Snoek FJ, Pouwer F. Associations between depressive symptoms and insulin resistance: the Hoorn Study. Dia-betologia 2006;49:2874-2877
34. Holt RI, Phillips DI, Jameson KA, Cooper C, Dennison EM, Peveler RC; Hertfordshire Cohort Study Group. The relationship between depression and diabetes mellitus: findings from the Hertfordshire Cohort Study. Diabet Med 2009;26:641-648
35. Timonen M, Rajala U, Jokelainen J, Keinänen-Kiukaanniemi S, Meyer-Rochow VB, Räsänen P. Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort. Mol Psychiatry 2006;11:929-933
36. Pearson S, Schmidt M, Patton G, et al. Depression and insulin resistance: cross-sectional associations in young adults. Diabetes Care 2010;33:1128-1133
37. Everson-Rose SA, Meyer PM, Powell LH, et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004;27:2856-2862
38. Hung YJ, Hsieh CH, Chen YJ, et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf) 2007; 67:784-789
39. Kauffman RP, Castracane VD, White DL, Baldock SD, Owens R. Impact of the selective serotonin reuptake inhibitor cit-alopram on insulin sensitivity, leptin and basal cortisol secretion in depressed and non-depressed euglycemic women of reproductive age. Gynecol Endocrinol 2005;21:129-137
40. Kahl KG, Bester M, Greggersen W, et al. Visceral fat deposition and insulin sensitivity in depressed women with and without comorbid borderline personality disorder. Psychosom Med 2005;67:407-412
41. Okamura F, Tashiro A, Utumi A, et al. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000;49:1255-1260
42. Golden SH, Lee HB, Schreiner PJ, et al. Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med 2007;69:529-536
43. Krishnamurthy P, Romagni P, Torvik S, et al.; P.O.W.E.R. (Premenopausal, Osteoporosis Women, Alendronate, Depression) Study Group. Glucocorticoid receptor gene polymorphisms in premenopausal women with major depression. Horm Metab Res 2008;40:194-198
44. Pan A, Ye X, Franco OH, et al. Insulin resistance and depressive symptoms in middle-aged and elderly Chinese: findings from the Nutrition and Health of Aging Population in China Study. J Affect Disord 2008;109:75-82
45. Roos C, Lidfeldt J, Agardh CD, et al. Insulin resistance and self-rated symptoms of depression inSwedish women withrisk factors for diabetes: the Women's Health in the Lund Area study. Metabolism 2007; 56:825-829
46. Schlotz W, Ambery P, Syddall HE, et al.; Hertfordshire Cohort Study Group. Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 2007;16:429-436
47. Timonen M, Salmenkaita I, Jokelainen J, et al. Insulin resistance and depressive symptoms in young adult males: findings from Finnish military conscripts. Psy-chosom Med 2007;69:723-728
48. Nouwen A, Winkley K, Twisk J, et al.; European Depression in Diabetes (EDID) Research Consortium. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010;53:2480-2486
49. Pan A, Sun Q, Czernichow S, et al. Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes (Lond) 2012;36: 595-602
50. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317-329
51. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009;71:171-186
52. Black PH. The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav Immun 2003; 17:350-364
53. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for non-compliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101-2107
54. Marcus MD, Wing RR, Guare J, Blair EH, Jawad A. Lifetime prevalence of major depression and its effect on treatment outcome in obese type II diabetic patients. Diabetes Care 1992;15:253-255
55. McDowell I. Measuring Health: A Guide to Rating Scales and Questionnaires. Newell C, Ed. New York, Oxford University Press, 1987
56. Kessler RC. The categorical versus dimensional assessment controversy in the sociology of mental illness. J Health Soc Behav 2002;43:171-188
57. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Ho-meostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-419
58. Rabasa-Lhoret R, Bastard JP, Jan V, et al. Modified quantitative insulin sensitivity check index is better correlated to hy-perinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 2003;88: 4917-4923
59. Cobelli C, Caumo A, Omenetto M. Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model. Am J Physiol 1999;277:E481-E488